Shares of GH Research PLC (NASDAQ:GHRS – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $16.32, but opened at $15.65. GH Research shares last traded at $15.06, with a volume of 844,915 shares.
Analysts Set New Price Targets
Several research firms have recently issued reports on GHRS. HC Wainwright reissued a “buy” rating and issued a $40.00 price objective on shares of GH Research in a research report on Monday, January 27th. Canaccord Genuity Group lowered their price objective on GH Research from $31.00 to $28.00 and set a “buy” rating for the company in a report on Monday, November 18th.
Check Out Our Latest Stock Report on GHRS
GH Research Price Performance
Hedge Funds Weigh In On GH Research
A hedge fund recently raised its stake in GH Research stock. RA Capital Management L.P. grew its stake in GH Research PLC (NASDAQ:GHRS – Free Report) by 1.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,686,689 shares of the company’s stock after buying an additional 85,000 shares during the period. RA Capital Management L.P. owned approximately 12.85% of GH Research worth $44,734,000 as of its most recent SEC filing. 56.90% of the stock is owned by institutional investors.
GH Research Company Profile
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).
Read More
- Five stocks we like better than GH Research
- Why is the Ex-Dividend Date Significant to Investors?
- Broadcom’s Bull Run: Time to Jump In?
- How to Choose Top Rated Stocks
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- How to trade using analyst ratings
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
Receive News & Ratings for GH Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GH Research and related companies with MarketBeat.com's FREE daily email newsletter.